Related Experiment Video
Updated: Dec 28, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Recent developments in the field of vascular liver diseases
1Service d'hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Université de Paris and Inserm, Clichy la Garenne, France.
This review covers updates in vascular liver disease, including Abernethy malformation, portal vein thrombosis in cirrhosis, and recanalization techniques. It also discusses direct oral anticoagulants for these conditions.
Area of Science:
- Hepatology
- Vascular Medicine
- Interventional Radiology
Background:
- Vascular liver diseases encompass a range of conditions affecting blood flow in the liver.
- Recent advancements necessitate updated clinical knowledge for effective management.
- Key areas include congenital anomalies, thrombotic events, and interventional procedures.
Purpose of the Study:
- To provide a comprehensive update on recent developments in vascular liver disease.
- To review current data on Abernethy malformation in adult patients.
- To discuss progress in managing portal vein thrombosis, recanalization techniques, and anticoagulant therapies.
Main Methods:
- Literature review of recent studies and clinical data.
- Synthesis of information on Abernethy malformation, portal vein thrombosis, and liver disease.
- Analysis of outcomes related to portal vein recanalization and direct oral anticoagulants.
Main Results:
- Updated insights into the presentation and management of Abernethy malformation in adults.
- Current understanding of portal vein thrombosis in cirrhosis, including risk factors and treatment.
- Evidence on the efficacy and safety of direct oral anticoagulants in vascular liver disease.
Conclusions:
- Continuous expansion of knowledge in vascular liver disease requires regular updates.
- Advances in recanalization techniques offer new therapeutic options.
- Direct oral anticoagulants show promise in managing vascular liver disease complications.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

